止血带使用是否影响肥胖患者初次全膝关节置换术的患者报告结局:倾向性匹配研究
该回顾性倾向性匹配研究纳入5,197例初次全膝关节置换术患者,筛选BMI>30且随访至少2年的肥胖患者,按1:3匹配后比较使用与不使用止血带组的患者报告结局和并发症率。结果显示两组并发症率相当(P>0.05),多个PROM绝对评分有差异(P<0.05),但变化评分和临床意义改善比例相似(P>0.05)。
要点
- 肥胖患者初次TKA使用止血带不增加90天、1年和2年并发症率。
- 止血带组与无止血带组PROM变化评分和临床意义改善比例无差异。
- 部分PROM绝对评分存在差异,但临床意义有限。
核心结论
- 肥胖患者初次全膝关节置换术中,止血带使用与90天、1年和2年并发症率无差异相关。
- 止血带使用与临床意义的患者感知结局无差异相关。
研究设计与样本
- 单机构回顾性 review,识别5,197例连续初次全膝关节置换术患者。
- 纳入BMI>30且随访至少2年的肥胖患者,按年龄、性别、种族、BMI和合并症进行1:3倾向性匹配。
- 匹配后无止血带组281例,止血带组843例。
主要发现
- 无止血带组与止血带组并发症率相当(P>0.05)。
- 多个PROM绝对评分存在差异(P<0.05),但变化评分和临床意义改善与恶化比例相似(P>0.05)。
关键数值与推荐
- 纳入标准:BMI>30,随访至少2年。
- 匹配后样本量:无止血带组281例,止血带组843例。
- 并发症率比较P>0.05;PROM绝对评分差异P<0.05;变化评分和临床意义改善比例P>0.05。
临床怎么用
- 肥胖患者初次全膝关节置换术中,止血带使用不影响并发症率和临床意义的患者报告结局。
- 临床决策可基于其他因素考虑止血带使用,而非担心对肥胖患者PROM的负面影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obese patients are at increased risk of complications after primary total knee arthroplasty (TKA). Tourniquets are commonly used intraoperatively to reduce bleeding and improve visualization, but their impact on patient-reported outcome measures (PROMs) in obese populations is not well understood. This study aimed to compare PROMs and complication rates after primary TKA in obese patients who did and did not have tourniquets using a propensity-matched analysis. METHODS: A retrospective review identified 5,197 consecutive patients who underwent primary TKA at a single institution. Patients who had a body mass index > 30 and at least two years of follow-up were propensity-matched 1:3 based on age, sex, race, body mass index, and comorbidities. The 90-day, one-year, and two-year complication rates were recorded. The Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form, Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-Physical, PROMIS Global Health-Mental, and PROMIS Physical Function Short Form 10a were extracted for both groups. Absolute scores, changes in (delta) scores, and minimal clinically important difference achievement were computed and compared. After matching, 281 patients in the no-tourniquet group and 843 patients in the tourniquet group were available for analysis. RESULTS: Patients who had TKA without a tourniquet experienced complication rates comparable to those who received a tourniquet (P > 0.05). There were differences in absolute scores in multiple PROMs (P < 0.05), but similar delta scores and proportions of clinically meaningful improvement and worsening were present in both groups (P > 0.05). CONCLUSIONS: In obese patients undergoing primary TKA, tourniquet use was associated with no differences in 90-day or one- and two-year complication rates or clinically meaningful patient-perceived outcomes. These findings are consistent with prior studies in general TKA populations, which have shown that tourniquet use does not substantially affect complication or patient-reported satisfaction benefits.
引用
- Freeman IA, Ilyas MH, Mannina CM, et al. Does Tourniquet Use Influence Patient-Reported Outcomes in Obese Patients Undergoing Primary Total Knee Arthroplasty? A Propensity-Matched Study. J Arthroplasty. 2026. PMID: 42031180. doi:10.1016/j.arth.2026.04.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。